tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Terence Flynn, 250 are a HOLD (46.73%), 45 are a SELL (8.41%), 240 are a BUY (44.86%).
Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 65.62% that have a potential upside of 24.06% achieved within 253 days.
Terence Flynn’s has documented 1,078 price targets and ratings displayed on 44 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALMS, Alumis Common Stock at 02-Sep-2026.
Analyst best performing recommendations are on XLRN (ACCELERON PHARMA).
The best stock recommendation documented was for XLRN (ACCELERON PHARMA) at 3/22/2021. The price target of $132 was fulfilled within 2 days with a profit of $11.64 (8.1%) receiving and performance score of 40.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Sep-2026
$50
$9.15 (22.40%)
$43
7 days ago
(24-Sep-2026)
1/2 (50%)
$9.21 (22.58%)
324
Buy Since 08-Oct-2025
$56
$15.15 (37.09%)
$56
9 days ago
(22-Sep-2026)
8/10 (80%)
$12.71 (29.36%)
304
Buy Since 18-Mar-2024
$61
$20.15 (49.33%)
$45
9 days ago
(22-Sep-2026)
5/6 (83.33%)
$17.71 (40.91%)
531
Buy Since 28-May-2025
$62
$21.15 (51.77%)
$62
10 days ago
(21-Sep-2026)
6/9 (66.67%)
$17.82 (40.33%)
223
Hold Since 06-Dec-2022
$61
$20.15 (49.33%)
$60
2 months 2 days ago
(29-Jul-2026)
9/11 (81.82%)
$12.66 (26.19%)
123
Which stock is Terence Flynn most bullish on?
Which stock is Terence Flynn most reserved on?
What Year was the first public recommendation made by Terence Flynn?
